Narrow lanes in New Delhi's old town embody the history of the Indian capital, with street food, bazaars and architecture that have captured the imagination of people from around the world.
Thursday, March 4, 2021
How a coronavirus variant is overrunning Brazil
The numbers are alarming. On Tuesday, a new daily record was broken when 1,726 people died of COVID-19 in Brazil. The average death rate over the past week was 1,274. That's almost 25% higher than two weeks ago.
"We are currently experiencing the worst moment of the pandemic, with daily death tolls breaking new records and overburdened intensive care units all over the country," microbiologist Natalia Pasternak told DW.
Over 257,000 Brazilians have died of COVID-19 already. But the spread of the virus has picked up dramatically. On Tuesday, almost 60,000 new cases were registered.
Germany says AstraZeneca vaccine OK for over-65s after all
Germany's independent Standing Committee on Vaccination (Stiko) said on Thursday that the AstraZeneca vaccine can be administered to older people.
Germany had originally balked at approving the vaccine for those aged 65 and over due to efficacy concerns.
However, new data — and quite possibly the faltering national attempts to start vaccinating — caused German health authorities to change their minds.
EU blocks export of AstraZeneca COVID-19 vaccines to Australia
The European Commission and Italy have blocked a shipment of AstraZeneca's COVID-19 vaccine destined for Australia after the pharmaceutical company did not fulfil its European Union contract commitments, sources said on Thursday.
It is the first time the EU has employed an export control mechanism it set up to ensure drug manufacturers respect their contracts.
The sources said AstraZeneca had reportedly requested authorization from the Italian government to export some 250,000 doses from its Anagni plant, close to Rome. The site is owned by US group Catalent.
COVID-19: Italy and EU block Oxford-AstraZeneca vaccine shipment to Australia as shortages row escalates
The British-Swedish drug manufacturer had failed to meet its EU contract commitments so the Italian government refused its request to export 250,000 doses from its Anagni plant near Rome.
Italy made the request and it was signed off by the European Commission under a new export control system that came into law on 30 January. This is the first time it has been used by a member state.
Self-Proclaimed Billionaire Trump Now Begging Small-Dollar Donors For Money
ORLANDO, Fla. ― After years of claiming he was so rich he didn’t need anyone else’s money for his political campaigns, Donald Trump is officially asking small-dollar donors ― many of them lower income and older ― to send him cash, potentially hurting the Republican Party’s small-dollar program.
The request was tucked in near the end of his first public appearance since leaving the presidency Jan. 20, a 90-minute speech Sunday that largely recycled his oft-repeated lies about the November election and his record in office.
California To Give 40% Of Vaccine Doses To Vulnerable Areas
SACRAMENTO, Calif. (AP) — California will begin setting aside 40% of all vaccine doses for the state’s most vulnerable neighborhoods in an effort to inoculate people most at risk from the coronavirus and get the state’s economy open more quickly.
Two officials in Gov. Gavin Newsom’s administration shared details Wednesday on condition of anonymity.
The doses will be spread out among 400 ZIP codes with about 8 million people eligible for shots. Many of the neighborhoods are concentrated in Los Angeles County and the Central Valley.
House Passes Landmark Voting Rights Bill, Setting Up First Major Filibuster Fight
The For the People Act, congressional Democrats’ top legislative priority, passed with 220 Democrats in support and one Democrat (Rep. Bennie Thompson of Mississippi) and 209 Republicans in opposition. (Two Republicans did not vote.) This encapsulates a major contrast between the nation’s two major political parties: One is pushing to expand access to the ballot, the other is trying to restrict it.
Subscribe to:
Comments (Atom)